SymBiosis Capital Partners, LLC

Position in RANI — Rani Therapeutics Holdings, Inc.

CIK 2006045 BENTONVILLE, AR

Position in RANI

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$2,695,674

-$5,809,326 QoQ

Shares Held

3,667,585

-41.8% QoQ

Ownership

2.63%

of shares outstanding

% of Portfolio

5.11%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

SymBiosis Capital Partners, LLC holds $50,642,960 across 5 Biotechnology names. RANI ranks #4 (5.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EVMN	Evommune, Inc.	1,280,778	$29,445,086
2	IVA	Inventiva S.A.	2,354,000	$13,064,700
3	WVE	Wave Life Sciences, Inc.	750,000	$5,437,500
4	RANI	Rani Therapeutics Holdings, Inc. This page	3,667,585	$2,695,674
5	SRZN	Surrozen, Inc./DE	150,000	$0

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,695,674	3,667,585	-41.8%	Shares	Sole	2026-05-12
2025-12-31	$8,505,000	6,300,000	—	Shares	Sole	2026-02-12
No filing history on record for this holder in this stock.